Patents by Inventor Estefania ALVAREZ

Estefania ALVAREZ has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11937886
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses, Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Grant
    Filed: November 11, 2021
    Date of Patent: March 26, 2024
    Assignee: Hologic, Inc.
    Inventors: John Laviola, Shawn St. Pierre, Brian Stellmach, Lori Fontaine, Joseph A. Stand, III, Estefania Alvarez, Stephen Grantz, Michelle Dawn Lyman, Shannon Marie Butler, Yuliya Mathis
  • Publication number: 20240065614
    Abstract: Examples of the present disclosure describe systems and methods for the long-term, real-time active monitoring of a wireless implant. In aspects, a wireless biosensor may be implanted in a breast biopsy cavity. The biosensor may detect biochemical parameter data of the breast biopsy cavity and the human body. The biosensor may transmit the detected biochemical parameter data in real-time to a surveillance system wirelessly coupled to the biosensor. The surveillance system may then facilitate the evaluation of the biochemical parameter data. In examples, the evaluation may comprise detecting trends in a tumor's microenvironment, monitoring the progress of a treatment, or adjusting a treatment to tailor a personalized treatment.
    Type: Application
    Filed: September 11, 2023
    Publication date: February 29, 2024
    Applicant: Hologic, Inc.
    Inventor: Estefania ALVAREZ
  • Patent number: 11890299
    Abstract: A method of ablating a target body tissue, such as uterine endometrial lining tissue, includes applying an agent comprising HAuCl4 to the target body tissue, wherein the HAuCl4 has a molecular size greater than 50 microns, and removing the agent comprising HAuCl4 from the target tissue after ablation of the target tissue begins.
    Type: Grant
    Filed: May 29, 2020
    Date of Patent: February 6, 2024
    Assignee: Hologic, Inc.
    Inventors: Victor Manuel Solano Umaña, Estefania Alvarez
  • Patent number: 11877898
    Abstract: A biopsy site marker configured to expand upon deployment into a biopsy cavity, and visible under several different imaging modalities, comprises a superabsorbent hydrogel component and a radiopaque element. The hydrogel is in a compressed, dehydrated state prior to deployment to facilitate placement of the marker within the biopsy site, and thereafter expands upon deployment in the biopsy site. Such expansion limits migration of the site marker.
    Type: Grant
    Filed: September 27, 2017
    Date of Patent: January 23, 2024
    Assignee: HOLOGIC, INC.
    Inventors: Estefania Alvarez, Adam Kozak, Jaimee Robertson, Stephen Spiegelberg
  • Patent number: 11877857
    Abstract: Examples of the present disclosure describe systems and methods for the long-term, real-time active monitoring of a wireless implant. In aspects, a wireless biosensor may be implanted in a breast biopsy cavity. The biosensor may detect biochemical parameter data of the breast biopsy cavity and the human body. The biosensor may transmit the detected biochemical parameter data in real-time to a surveillance system wirelessly coupled to the biosensor. The surveillance system may then facilitate the evaluation of the biochemical parameter data. In examples, the evaluation may comprise detecting trends in a tumors microenvironment, monitoring the progress of a treatment, or adjusting a treatment to tailor a personalized treatment.
    Type: Grant
    Filed: September 10, 2018
    Date of Patent: January 23, 2024
    Assignee: Hologic, Inc.
    Inventor: Estefania Alvarez
  • Patent number: 11464585
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: October 11, 2022
    Assignee: Hologic, Inc.
    Inventors: John Laviola, Shawn St. Pierre, Brian Stellmach, Lori Fontaine, Joseph A. Stand, III, Estefania Alvarez, Stephen Grantz, Michelle Dawn Lyman, Shannon Marie Butler, Yuliya Mathis
  • Patent number: 11432883
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Grant
    Filed: October 25, 2021
    Date of Patent: September 6, 2022
    Assignee: Hologic, Inc.
    Inventors: John Laviola, Shawn St. Pierre, Brian Stellmach, Lori Fontaine, Joseph A. Stand, III, Estefania Alvarez, Stephen Grantz, Michelle Dawn Lyman, Shannon Marie Butler, Yuliya Mathis
  • Publication number: 20220110699
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses, Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: December 21, 2021
    Publication date: April 14, 2022
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Publication number: 20220071714
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: November 12, 2021
    Publication date: March 10, 2022
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Publication number: 20220061930
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses, Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 3, 2022
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Publication number: 20220061931
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: November 11, 2021
    Publication date: March 3, 2022
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Publication number: 20220039879
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Publication number: 20220039878
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: October 25, 2021
    Publication date: February 10, 2022
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Patent number: 11234772
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Grant
    Filed: December 11, 2018
    Date of Patent: February 1, 2022
    Assignee: Hologic, Inc.
    Inventors: John Laviola, Shawn St. Pierre, Brian Stellmach, Lori Fontaine, Joseph A. Stand, III, Estefania Alvarez, Stephen Grantz, Michelle Dawn Lyman, Shannon Marie Butler, Yuliya Mathis
  • Publication number: 20210169579
    Abstract: Disclosed biopsy markers are adapted to serve as localization markers during a surgical procedure. Adaptation includes incorporation of materials detectable under ultrasound during surgery, as well as features for co-registration with image guidance or other real-time imaging technologies during surgery. Such biopsy markers, when used as localization markers, improve patient comfort and reduce challenges in surgical coordination and surgery time. Additional disclosed biopsy markers are adapted to serve as monitoring and/or detection apparatuses. Localization of an implanted marker may be done with ultrasound technology. Ultrasound image data is analyzed to identify the implanted marker. A distance to the marker or a lesion may be determined and displayed. The determined distance may be a distance between the ultrasound probe and the marker or lesion, a distance between the marker or lesion and an incision instrument, and/or a distance between the ultrasound probe and the incision instrument.
    Type: Application
    Filed: December 11, 2018
    Publication date: June 10, 2021
    Inventors: John LAVIOLA, Shawn ST. PIERRE, Brian STELLMACH, Lori FONTAINE, Joseph A. STAND, III, Estefania ALVAREZ, Stephen GRANTZ, Michelle Dawn LYMAN, Shannon Marie BUTLER, Yuliya MATHIS
  • Publication number: 20200405382
    Abstract: A method of ablating a target body tissue, such as uterine endometrial lining tissue, includes applying an agent comprising HAuCl4 to the target body tissue, wherein the HAuCl4 has a molecular size greater than 50 microns.
    Type: Application
    Filed: May 29, 2020
    Publication date: December 31, 2020
    Applicant: HOLOGIC, INC.
    Inventors: Victor Manuel Solano Umaña, Estefania Alvarez
  • Publication number: 20200275878
    Abstract: Examples of the present disclosure describe systems and methods for the long-term, real-time active monitoring of a wireless implant. In aspects, a wireless biosensor may be implanted in a breast biopsy cavity. The biosensor may detect biochemical parameter data of the breast biopsy cavity and the human body. The biosensor may transmit the detected biochemical parameter data in real-time to a surveillance system wirelessly coupled to the biosensor. The surveillance system may then facilitate the evaluation of the biochemical parameter data. In examples, the evaluation may comprise detecting trends in a tumors microenvironment, monitoring the progress of a treatment, or adjusting a treatment to tailor a personalized treatment.
    Type: Application
    Filed: September 10, 2018
    Publication date: September 3, 2020
    Inventor: Estefania ALVAREZ
  • Publication number: 20190282325
    Abstract: A biopsy site marker configured to expand upon deployment into a biopsy cavity, and visible under several different imaging modalities, comprises a superabsorbent hydrogel component and a radiopaque element. The hydrogel is in a compressed, dehydrated state prior to deployment to facilitate placement of the marker within the biopsy site, and thereafter expands upon deployment in the biopsy site. Such expansion limits migration of the site marker.
    Type: Application
    Filed: September 27, 2017
    Publication date: September 19, 2019
    Applicant: HOLOGIC, INC.
    Inventors: Estefania ALVAREZ, Adam KOZAK, Jaimee ROBERTSON, Stephen SPIEGELBERG